podophyllotoxin has been researched along with dichlororibofuranosylbenzimidazole in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leong, PM; Liber, HL; Little, JB; Terry, VH | 1 |
| Gupta, RS; Hodgson, M | 1 |
2 other study(ies) available for podophyllotoxin and dichlororibofuranosylbenzimidazole
| Article | Year |
|---|---|
X-rays mutate human lymphoblast cells at genetic loci that should respond only to point mutagens.
Topics: Dichlororibofuranosylbenzimidazole; Drug Resistance; Humans; Hypoxanthine Phosphoribosyltransferase; Lymphocytes; Mutation; Podophyllotoxin; Sodium-Potassium-Exchanging ATPase; Thymidine Kinase; X-Rays | 1986 |
Genetic markers in mouse teratocarcinoma cells. Selection and partial characterization of mutants resistant to toyocamycin, DRB and podophyllotoxin.
Topics: Adenosine Kinase; Animals; Cell Line; Dichlororibofuranosylbenzimidazole; Drug Resistance; Genetic Markers; Mice; Mutation; Podophyllotoxin; Teratoma; Toyocamycin | 1981 |